Modified Nucleosides
3'-Deoxycytidine
Quick view. We supply 3'-Deoxycytidine as a specialty product for nucleic acid chemistry and oligonucleotide research workflows. CAS 7057-33-2. Catalog target purity: Specification on request.
Product profile
3'-Deoxycytidine is classified as nucleoside or protected nucleoside intermediate (Formula C9H13N3O4; molecular weight 227.22).
3'-Deoxycytidine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 3'-Deoxycytidine, storage: 2-8°C. Form: Solid.
Names and search terms
Confirmed or normalized name variants
- 1-(3-Deoxypentofuranosyl)-4-imino-1,4-dihydropyrimidin-2-ol
- 3-DC
- antiviral agent
- 3’-deoxy-cytidin
- 3'-Deoxy-D-cytidine
- Cytidine, 3'-deoxy-
- 3'-deoxyribicytidine
- 3'-DEOXYCYTIDINE USP/EP/BP
Useful catalog search terms
- CAS 7057-33-2
- Nucleoside or protected nucleoside intermediate
- Modified Nucleosides
Physicochemical data
| InChI | InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-6(14)3-5(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s |
|---|---|
| InChIKey | ZHHOTKZTEUZTHX-SHYZEUOFSA-N |
| SMILES | OC[C@H]1O[C@@H](N2C=CC(N)=NC2=O)[C@H](O)C1 |
| Melting point | 230-232 °C |
| Boiling point | 497.6±55.0 °C(Predicted) |
| Density | 1.73±0.1 g/cm3(Predicted) |
| pKa | 14.01±0.60(Predicted) |
| Form | Solid |
| Color | White to light yellow |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosylmethionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-0185(R-/S-) 5-Carbamoylhydroxy methyluridine
Modified Nucleosides · CAS: N/A
BX-MN-0186(R-/S-)5-(1-Hydroxy)(methoxycarbonyl)methyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0187(R-/S-)5-Carboxyhydroxymethyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0719(R)-N-(2,3-dihydro-1H-indenyl)adenosine
Modified Nucleosides · CAS: 96392-15-3
Frequently asked questions
Can the package size for 3'-Deoxycytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0649 and CAS 7057-33-2, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry.